AstraZeneca Dodges Questions with Online Meeting

AstraZeneca has issued a directive urging shareholders to refrain from attending its annual general meeting in person this week. The pharmaceutical giant has designated the event as strictly online-only, a decision met with disapproval by groups advocating for greater corporate transparency.

This move is particularly contentious as it occurs amidst ongoing legal inquiries, leading critics to assert that it enables directors to avoid accountability. Campaigners like Luke Hildyard from ShareAction express concern that virtual-only AGMs diminish shareholder democracy and lead to increased risks.

Ministers are reportedly advancing plans to permit digital-only annual general meetings. However, opponents contend that such a shift would weaken the scrutiny faced by company leaders and negatively impact decision-making processes.